Kyverna Therapeutics, Inc. (KYTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$52.41M2024: -$114.25M2025: -$153.71M-$153.71M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$153.71M-34.5%
2024-$114.25M-118.0%
2023-$52.41M